Advanced Dental Of Monroe Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 475 Spotswood Englishtown Rd, Monroe, NJ 08831 Phone: 732-963-4700 |
Amara Dental Of Monroe, P.a. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 211 Applegarth Road, Suite 109, Monroe, NJ 08831 Phone: 732-561-5001 Fax: 732-561-5002 |
Columbia Brothers Dental Group Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 410 Spotswood Englishtown Rd, Monroe, NJ 08831 Phone: 732-251-5252 |
News Archive
As the coronavirus crisis lit up this spring, headlines about how the U.S. could innovate its way out of a pending ventilator shortage landed almost as hard and fast as the pandemic itself.
Immunomedics, Inc., a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today reported that consolidation treatment with fractionated yttrium-90 (Y-90) labeled epratuzumab, after induction therapy with rituximab and CHOP (R-CHOP) chemotherapy, improved remission status of adult patients with diffuse large B-cell lymphoma (DLBCL), a form of aggressive lymphoma.
Patients with rheumatic conditions are in need of symptom relief and some are turning to herbal cannabis as a treatment option. However, the effectiveness and safety of medical marijuana to treat symptoms of rheumatic conditions such as rheumatoid arthritis, lupus, or fibromyalgia is not supported by medical evidence. A new article published in Arthritis Care & Research, a journal of the American College of Rheumatology, explores the risks associated with using herbal cannabis for medicinal purposes and advises healthcare providers to discourage rheumatology patients from using this drug as therapy.
Researchers at North Carolina State University have developed a new analytical method that opens the door to faster processing of large amounts of information, with applications in fields as diverse as the military, medical diagnostics and homeland security.
According to the article, "myopia affects approximately 25 percent of the U.S. population, and it typically develops between eight and 16 years of age." Previous studies have reported that rigid contact lenses may slow myopia progression, but other studies have found that rigid contact lenses have no effect on myopia progression in children, the article states.
› Verified 5 days ago